2 High-Growth Stocks Under $20 That Make for Screaming Buys Right Now

SoFi reported Q1 2026 revenue of $1.10 billion, beating consensus by 4.87%, with GAAP net income up 134.45% year over year to $166.73 million and full-year adjusted net revenue guidance raised to about $4.655 billion. Sabre posted Q1 2026 revenue of $760.33 million, 8% growth, and a 21% jump in normalized adjusted EBITDA to $169.09 million while reaffirming about $585 million of full-year adjusted EBITDA. The article is broadly bullish on both names, citing operating momentum and, for SoFi, insider buying, though both stocks remain exposed to execution and leverage risks.

Analysis

The bigger read-through is that the market is rewarding self-funding growth and punishing anything that still looks balance-sheet fragile. SOFI sits on the right side of that divide: once deposit-funded lending and fee businesses compound together, the equity stops trading like a fintech and starts trading like a scaled financial platform with operating leverage. That creates a second-order effect where every quarter of stable credit and deposit growth can trigger multiple expansion rather than just EPS appreciation, especially if management keeps buying stock into weakness.

The main competitive signal in SOFI is not just against other consumer fintechs, but against regional banks and neobanks competing for the same low-cost funding and prime borrower base. If credit remains contained, the real upside is that SoFi can use its balance-sheet strength to outspend smaller rivals on customer acquisition while keeping funding costs structurally lower. The bear case is that a modest deterioration in charge-offs can quickly compress the valuation because the market is paying for consistency, not just growth.

SABR is a different setup: this is less a high-quality compounder and more a leveraged operating reset. The equity behaves like a call option on travel volumes and AI-driven workflow adoption, but the convexity is constrained by debt service, so the market will need proof that incremental EBITDA is sticking for several quarters before re-rating the stock. Second-order, any partner wins in agentic travel tech could pressure legacy distribution competitors and improve Sabre’s strategic relevance, but it also risks being treated as promotional until there is visible monetization.

Consensus is probably underestimating how much of the recent move in both names is about positioning rather than fundamentals. SOFI still has room to work higher if earnings hold and the insider-bid narrative persists, while SABR can continue to squeeze shorts if bookings and margins surprise again; but neither should be chased after a sharp green day. The right framing is asymmetry: SOFI is a months-to-years compounder with near-term execution risk, SABR is a trading vehicle with event-driven upside and materially higher downside if growth decelerates or financing stress reasserts.

Key Decisions for Investors

• Long SOFI on pullbacks toward the mid-$14s; target a 3-6 month hold with upside to analyst target zone if deposits and revenue growth remain intact. Risk/reward favors ~2:1 upside/downside as long as charge-offs stay near current levels.
• For SOFI, consider a call spread instead of common stock for a defined-risk way to express a 6-9 month re-rating trade; use strikes around current levels to capture multiple expansion without overpaying for volatility.
• Treat SABR as a tactical long only after confirmation of follow-through in bookings or margin prints; best entry is on post-earnings consolidation rather than momentum chasing. Expect high beta and size it as a small sleeve position.
• Use SABR as a pair-trade leg versus a higher-quality travel-tech or payments name if available; the long should be the operating leverage/high-conviction turnaround, with the short hedging broad travel exposure and isolating balance-sheet risk.
• Avoid shorting SOFI outright unless credit trends reverse for at least one full quarter; the combination of funding strength and insider accumulation makes downside asymmetric only if loan performance materially worsens.